01276 恒瑞醫藥
公司資料 - 財務比率
江蘇恒瑞醫藥股份有限公司 股票編號: 01276
JIANGSU HENGRUI PHARMACEUTICALS CO., LTD. 集團網址: http://www.hengrui.com
盈利能力分析
2024/12 2023/12 2022/12    
資產回報率 (%)13.493%9.988%9.219%
股東資金回報率 (%)14.739%10.991%10.328%
資本運用回報率 (%)13.626%10.435%10.086%
 
邊際利潤分析
毛利率 (%)86.249%84.552%83.612%
未計利息、稅項、折舊及攤銷前利潤率 (%)26.673%22.185%20.179%
稅前邊際利潤率 (%)25.620%20.452%18.653%
純利率 (%)22.643%18.854%18.361%
 
變現能力分析
流動比率 (X)9.719 X12.252 X8.500 X
速動比率 (X)9.054 X11.346 X7.827 X
 
財務槓桿分析
總負債 / 總資產比率 (%)8.069%6.284%9.341%
總負債 / 股東資金比率 (%)8.887%6.799%10.464%
非流動負債 / 股東資金比率 (%)0.905%0.489%0.843%
利息盈利率 (倍)1290.745 X791.366 X612.384 X
 
營運效率分析
存貨周轉率日數 (日)30.854 Day(s)38.105 Day(s)42.042 Day(s)
 

Copyright © 2025 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.